Quantbot Technologies LP Invitae Corp Transaction History

Quantbot Technologies LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$2.13 - $9.01 $423,377 - $1.79 Million	198,769 Added 98.18%	401,216 $978,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $1.27 Million - $3.14 Million	201,521 Added 21762.53%	202,447 $1.61 Million
Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $13,612 - $26,548	926 New	926 $14,000
Q3 2021 Nov 09, 2021	SELL	$24.31 - $33.6 $353,029 - $487,939	-14,522 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $378,878 - $586,688	14,522 New	14,522 $489,000

Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $2,281 - $3,928	-69 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $383,433 - $563,036	-9,809 Reduced 99.3%	69 $2,000
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $252,401 - $396,580	8,878 Added 887.8%	9,878 $428,000
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $11,710 - $30,290	1,000 New	1,000 $30,000
Q2 2019 Aug 13, 2019	SELL	$17.37 - $26.27 $12,159 - $18,389	-700 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$10.65 - $25.75 $7,455 - $18,025	700 New	700 $16,000
Q4 2018 Feb 13, 2019	SELL	$9.26 - $16.38 $56,865 - $100,589	-6,141 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$7.54 - $18.31 $46,303 - $112,441	6,141 New	6,141 $102,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.